Global pricing assessment and forecast

• Life Sciences
• CRA Insights

ESMO 2025 Review: Bring me the horizon

From these sessions, CRA’s Aaron Everitt highlighted that while there are still relevant data releases and findings on existing immune checkpoint inhibitors,...

• Life Sciences
• CRA Insights

GLP-1 access is shifting – Are stakeholders ready?

CRA’s Becky Davis examines how these dramatic price reductions, combined with Direct-to-Patient distribution models, may be accelerating employer migration...

• Life Sciences
• Speaking Engagement

• November 9-12, 2025
• Glasgow, Scotland

ISPOR Europe 2025

Abhishek Kumar, Elaine Damato and Alice Kim present their poster titled “Staying Competitive in a Crowded Vaccines Market: Is There Room for a Third or Fourth...

• International Arbitration
• Speaking Engagement

• November 27, 2025
• Milan, Italy

16th CAM Annual Conference

Greg Bell is a panelist during the session titled “Navigating Life Sciences disputes. An arbitrator’s perspective.” For more information on this event, click...